CVS Health Co. (NYSE:CVS) Shares Sold by Orion Portfolio Solutions LLC

Orion Portfolio Solutions LLC trimmed its position in shares of CVS Health Co. (NYSE:CVS) by 19.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 53,953 shares of the pharmacy operator’s stock after selling 12,725 shares during the period. Orion Portfolio Solutions LLC’s holdings in CVS Health were worth $2,422,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Nomura Asset Management Co. Ltd. increased its holdings in shares of CVS Health by 3.6% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 1,494,378 shares of the pharmacy operator’s stock valued at $67,083,000 after purchasing an additional 51,652 shares during the period. New Age Alpha Advisors LLC acquired a new position in CVS Health during the 4th quarter valued at about $3,351,000. Norges Bank bought a new stake in shares of CVS Health during the 4th quarter worth about $839,574,000. Caisse Des Depots ET Consignations acquired a new stake in shares of CVS Health in the 4th quarter worth approximately $2,631,000. Finally, NEOS Investment Management LLC boosted its holdings in shares of CVS Health by 31.6% in the fourth quarter. NEOS Investment Management LLC now owns 77,773 shares of the pharmacy operator’s stock valued at $3,491,000 after acquiring an additional 18,667 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CVS. Barclays upped their target price on CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. Truist Financial raised their target price on CVS Health from $60.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Edward Jones raised shares of CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. StockNews.com raised shares of CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday, February 13th. Finally, Cantor Fitzgerald raised shares of CVS Health from a “neutral” rating to an “overweight” rating in a research note on Wednesday, February 12th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $70.39.

Insiders Place Their Bets

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the business’s stock in a transaction dated Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the acquisition, the director now owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP James David Clark sold 7,513 shares of the company’s stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the sale, the senior vice president now owns 8,394 shares of the company’s stock, valued at $556,941.90. This represents a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.24% of the company’s stock.

CVS Health Trading Up 0.2 %

NYSE:CVS opened at $67.88 on Wednesday. The stock has a market cap of $85.59 billion, a PE ratio of 18.55, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $75.27. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The stock’s 50-day moving average is $62.72 and its two-hundred day moving average is $57.83.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, equities research analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd will be paid a $0.665 dividend. The ex-dividend date is Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.92%. CVS Health’s dividend payout ratio (DPR) is currently 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.